GGrantIndex
Sort

82,697 grants matching vaccine development

Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa

$728,861
Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AI

Herpesvirus Pathogenesis and Vaccine Development

$728,727
Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D

$728,669
Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2021 · AI

CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D

$728,669
Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2024 · AI

CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D

$728,669
Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2022 · AI

Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain

$728,655
Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2015 · AI

Development of a hamster model for hepatitis B virus infection

$728,653
Zhongde Wang · Utah State University · R01 · FY2025 · AI

Animal and Laboratory Core

$728,637
Todd M Allen · Massachusetts General Hospital · P01 · FY2014 · AI

Cellular Immune Responses to RSV infection in Mice

$728,613
Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Small Molecule Protease Inhibitors against MERS-CoV

$728,584
Kyeong-Ok Chang · Kansas State University · R01 · FY2022 · AI

Mechanistic studies of BLyS-mediated modulation in HIV-1 Env-specific antibody responses

$728,557
Michael Paul Cancro · University Of Pennsylvania · R01 · FY2015 · AI

Structural and functional basis of ultra potent CHKV neutralization by human mAbs

$728,541
James E Crowe · Vanderbilt University Medical Center · R01 · FY2017 · AI

Personalized Adoptive T-cell Therapy for AML

$728,501
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA

Next generation mosquito control through technology-driven trap development and artificial intelligence guided detection of mosquito breeding habitats

$728,486
Melissa Suzanne Nolan · University Of South Carolina At Columbia · R01 · FY2024 · AI

Preclinical Evaluation of Novel Adenovirus Vectors

$728,482
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2006 · AI

Lead Optimization of DHODH Inhibitors for Malaria

$728,403
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2020 · AI

Novel Adenovirus Vaccine Vectors for HIV/SIV

$728,351
Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2008 · AI

Adolescent health behaviors in the time of COVID-19

$728,345
Michele Ybarra · Center For Innovative Public Health Research · R01 · FY2021 · HD

Development of Therapeutic Inhibitors to Anthrax Toxins

$728,317
University Of Texas Medical Br Galveston · U01 · FY2003 · AI

Early Innate/IgA Anti-HIV/SIV Response in Exposed Uninfected

$728,314
Luis J. Montaner · Wistar Institute · R01 · FY2012 · AI

Developmental Research Plan

$728,262
David H Walker · University Of Texas Med Br Galveston · U54 · FY2009 · AI

Lymphoma Studies

$728,259
Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA

Gonococcal Vaccine Evaluation in a Humanized Mouse Model

$728,235
Lee Mark Wetzler · Boston Medical Center · R01 · FY2017 · AI

Impact of eliminating nonmedical exemptions in California

$728,232
Jason Lee Schwartz · Yale University · R01 · FY2020 · AI

Gene Transfer and Somatic Cell Engineering Core

$728,230
Isabelle Riviere · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA